On May 2, 2018, BenchSci announced that it has secured US$8 million in its Series A Financing round. The round was led by Montreal’s iNovia Capital with participation from Google’s AI-focused venture fund, Gradient Ventures, and return investors Golden Venture Partners, Afore Capital, Real Ventures, and Radical Ventures.
The funds will be used by BenchSci to expand its team of engineers and scientists, implement new sales and marketing programs to drive new customer acquisition, and scale its AI technology used by researchers to accelerate biomedical discoveries.
BenchSci a Toronto-based biomedical startup that uses machine learning to scan millions of data points in biomedical research papers, generating searchable results to help shorten the drug discovery process.
Osler, Hoskin & Harcourt LLP represented BenchSci with a team consisting of Chad Bayne, Justin Dharamdial and Jeremy Lin (Corporate).
Key Contact
Partner, Emerging and High Growth Companies, Toronto
Team
Associate, Emerging and High Growth Companies, Toronto
Partner, Emerging and High Growth Companies, Toronto
